186 related articles for article (PubMed ID: 30674748)
1. Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.
Tesena P; Yingchutrakul Y; Roytrakul S; Wongtawan T; Angkanaporn K
J Vet Med Sci; 2019 Mar; 81(3):418-424. PubMed ID: 30674748
[TBL] [Abstract][Full Text] [Related]
2. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic effects of Glycyrrhiza glabra root extract on phenylbutazone-induced Equine Glandular Gastric Disease (EGGD).
Ahmadnejad M; Jalilzadeh-Amin G; Sykes BW
J Equine Vet Sci; 2022 Nov; 118():104088. PubMed ID: 35908599
[TBL] [Abstract][Full Text] [Related]
4. Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E
Pedersen SK; Cribb AE; Read EK; French D; Banse HE
J Vet Pharmacol Ther; 2018 Apr; 41(2):239-245. PubMed ID: 29148168
[TBL] [Abstract][Full Text] [Related]
5. Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
Li Z; Du S; Wang X; Zhang L; Liu X; Fan Q; Yang H; Gao R
Equine Vet J; 2024 May; 56(3):562-572. PubMed ID: 37337455
[TBL] [Abstract][Full Text] [Related]
6. Equine gamma herpesvirus presence and viral load are not associated with equine glandular gastric disease.
Thompson RN; Pearson E; McDonough SP; Iannitti H; Van de Walle GR; Banse H; Perkins GA; Tomlinson JE
Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38484465
[TBL] [Abstract][Full Text] [Related]
7. Gastric microbiome in horses with and without equine glandular gastric disease.
Paul LJ; Ericsson AC; Andrews FM; Keowen ML; Morales Yniguez F; Garza F; Banse HE
J Vet Intern Med; 2021 Sep; 35(5):2458-2464. PubMed ID: 34351018
[TBL] [Abstract][Full Text] [Related]
8. A study comparing the healthy and diseased equine glandular gastric microbiota sampled with sheathed transendoscopic cytology brushes.
Voss SJ; McGuinness DH; Weir W; Sutton DGM
J Equine Vet Sci; 2022 Sep; 116():104002. PubMed ID: 35490972
[TBL] [Abstract][Full Text] [Related]
9. Management factors and clinical implications of glandular and squamous gastric disease in horses.
Sykes BW; Bowen M; Habershon-Butcher JL; Green M; Hallowell GD
J Vet Intern Med; 2019 Jan; 33(1):233-240. PubMed ID: 30499188
[TBL] [Abstract][Full Text] [Related]
10. Field study examining the mucosal microbiome in equine glandular gastric disease.
Paul LJ; Ericsson AC; Andrews FM; McAdams Z; Keowen ML; St Blanc MP; Banse HE
PLoS One; 2023; 18(12):e0295697. PubMed ID: 38060520
[TBL] [Abstract][Full Text] [Related]
11. Increased adrenocortical response to adrenocorticotropic hormone (ACTH) in sport horses with equine glandular gastric disease (EGGD).
Scheidegger MD; Gerber V; Bruckmaier RM; van der Kolk JH; Burger D; Ramseyer A
Vet J; 2017 Oct; 228():7-12. PubMed ID: 29153110
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and risk factors for equine glandular and squamous gastric disease in polo horses.
Banse HE; MacLeod H; Crosby C; Windeyer MC
Can Vet J; 2018 Aug; 59(8):880-884. PubMed ID: 30104780
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Equine Gastric Glandular Disease: A Case-Control Study in a Finnish Referral Hospital Population.
Mönki J; Hewetson M; Virtala AM
J Vet Intern Med; 2016 Jul; 30(4):1270-5. PubMed ID: 27461724
[TBL] [Abstract][Full Text] [Related]
14. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
Monreal L; Sabaté D; Segura D; Mayós I; Homedes J
Res Vet Sci; 2004 Apr; 76(2):145-9. PubMed ID: 14672858
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gastrointestinal inflammatory cell type in equine glandular gastric disease.
Banse HE; Piero FD; Andrews FM; Garcia-Abarca N; Watanabe TTN
Am J Vet Res; 2023 Dec; 84(12):. PubMed ID: 38041943
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.
MacAllister CG; Morgan SJ; Borne AT; Pollet RA
J Am Vet Med Assoc; 1993 Jan; 202(1):71-7. PubMed ID: 8420909
[TBL] [Abstract][Full Text] [Related]
17. Effects of meloxicam and phenylbutazone on equine gastric mucosal permeability.
D'Arcy-Moskwa E; Noble GK; Weston LA; Boston R; Raidal SL
J Vet Intern Med; 2012; 26(6):1494-9. PubMed ID: 23083114
[TBL] [Abstract][Full Text] [Related]
18. Effect of omeprazole and sucralfate on gastrointestinal injury in a fasting/NSAID model.
Bishop RC; Kemper AM; Wilkins PA; McCoy AM
Equine Vet J; 2021 Oct; ():. PubMed ID: 34719063
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a questionnaire to detect the risk of developing ESGD or EGGD in horses.
Busechian S; Sgorbini M; Orvieto S; Pisello L; Zappulla F; Briganti A; Nocera I; Conte G; Rueca F
Prev Vet Med; 2021 Mar; 188():105285. PubMed ID: 33530014
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for equine glandular and squamous gastric disease in show jumping Warmbloods.
Pedersen SK; Cribb AE; Windeyer MC; Read EK; French D; Banse HE
Equine Vet J; 2018 Nov; 50(6):747-751. PubMed ID: 29660168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
